BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Pharm Country

  FDA Hits Verrica With Third CRL For Lead Drug Candidate VP-102

  In the third and most recent FDA letter, Verrica noted that none of the issues were specific to VP-102 and how it is manufactured.

  May 25, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Samsung to Invest $356 Billion into Chipmaking, Biopharma

  Most of Samsung’s investment will be in South Korea, and it expects to create 80,000 new jobs through 2026, or about 16,000 positions annually.

  May 25, 2022

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Global Roundup: Iceland’s Alvotech Hits Mark with Biosimilar to Janssen’s Stelara

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  May 25, 2022

   · 

  7 min read

   · 

  Alex Keown
• 

  Job Trends

  $2.1B Eli Lilly Expansion to Add 500 New Jobs in Indiana

  When the two new sites are up and running, Eli Lilly predicted the project will create up to 500 new jobs - with the expectation of four indirect jobs for each full-time position, based on industry data.

  May 25, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Two Remarkable Women of Takeda’s C-Suite Make the Professional Personal

  At the start of Takeda’s fiscal year on April 1, Ramona Sequeira and Julie Kim stepped into new positions on the company’s executive leadership team and became role models for women.

  May 25, 2022

   · 

  9 min read

   · 

  Abbey Glasure
• 

  Drug Development

  Invectys is Pioneering HLA-G Immune Checkpoint Inhibitors in Cancer Therapeutics

  Invectys is one of only a few companies investigating HLA-G, a natural immune checkpoint inhibitor, for solid tumors.

  May 25, 2022

   · 

  4 min read

   · 

  Gail Dutton
• 

  Career Advice

  How to Negotiate Stock Options With Your Employer

  There are many reasons why you might want to negotiate your stock options. Read on to discover what stock options are and how to negotiate your stock options with your employer.

  May 25, 2022

   · 

  5 min read

   · 

  Franklin Carpenter
• 

  Drug Development

  United Therapeutics Gets FDA Green Light For First Inhaled Hypertension Therapeutic

  Tyvaso DPI marks the first approval of a dry powder inhaler for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

  May 25, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  CureVac and myNEO will Leverage mRNA Learnings for Cancer Vaccines

  Germany’s CureVac is partnering with Belgium’s myNEO to identify specific cancer antigens in order to develop novel mRNA immunotherapies for cancer vaccines.

  May 25, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Janssen Touts Positive Data For Tremfya, Stelara

  Janssen shared positive updates from ongoing trials on candidate therapies for Crohn’s disease and ulcerative colitis at Digestive Disease Week in San Diego, California.

  May 25, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN